Processa Pharmaceuticals, Inc. Common (PCSA) is a publicly traded Healthcare sector company. As of July 29, 2026, PCSA trades at $2.03 with a market cap of $7.17M and a P/E ratio of -0.27. PCSA moved -34.43% today. Year to date, PCSA is +5.90%; over the trailing twelve months it is -47.30%. Its 52-week range spans $1.67 to $37.50. Rallies surfaces PCSA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for PCSA shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $2.03 |
| Market Cap | $7.17M |
| P/E Ratio | -0.27 |
| EPS | $-10.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $37.50 |
| 52-Week Low | $1.67 |
| Volume | 9.20M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-13.56M |
| Gross Margin | 0.00% |
PCSA analyst coverage data. Average price target: $0.00.